Deal Snapshot
THERMO FISHER SCIENTIFIC TO ACQUIRE DUTCH DIAGNOSTICS FIRM QIAGEN FOR USD 11.5BN
Wednesday 04 March 2020

US-based life science company Thermo Fisher Scientific Inc. (NYSE: TMO) has agreed to acquire Dutch molecular diagnostics and sample preparation technologies company Qiagen N.V. (NYSE: QGEN) for EUR 39 per share in cash, the companies said.
The boards of directors of both firms, as well as the managing board of Qiagen, have unanimously approved Thermo Fisher's proposal.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 04/03/2020
Target: Qiagen N.V.
Country: Netherlands
Deal Size: 11.5bn (USD)
Sector: Biotechnology
Type: Corporate acquisition
Financing: Cash
Status: Agreed
Vendor:
Buyer: Thermo Fisher Scientific Inc
Buyer Advisor: J.P. Morgan Securities , Morgan Stanley and Co. LLC , Wachtell, Lipton, Rosen and Katz
Comment:


Options